Functional evaluation of chimeric antigen receptor T-cell anti-CD123 from immune-mediated inflammatory disease patients for novel plasmacytoid dendritic cell–targeted immunotherapy
Journal of Allergy and Clinical Immunology · 2026-09
DOI: 10.1016/j.jaci.2026.08.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-09. Verfasst von Blandine Caël und 11 weiteren Autor:innen. Beteiligte Einrichtung: Univeristé Marie et Louis Pasteur, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Besançon, Franc…. Die Arbeit nennt 49 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy is a promising approach for immune-mediated inflammatory diseases (IMIDs). Plasmacytoid dendritic cells (pDCs), which infiltrate tissues and secrete type I interferons, play a central early role in IMIDs and represent an attractive therapeutic target. OBJECTIVE: Given the high CD123 expression on pDCs, we assessed the potential of CD123 CAR-T cells to eliminate pDCs across multiple IMIDs. METHODS: In the CARDA2I study, patients with psoriasis, hidradenitis suppurativa, systemic lupus erythematosus, or systemic sclerosis were enrolled regardless of disease severity or treatment. After peripheral blood mononuclear cells were collected from patients and healthy donors (HDs), extended phenotype T cells were characterized at day 0 (D0) and after 10 days of expansion (D10). CAR-T cell functionality was assessed by coculture with autologous peripheral blood mononuclear cells and in BRGSF-HIS mice treated with human Flt3 ligand and imiquimod-induced psoriasis. RESULTS: Patient T cells showed phenotypic alterations at D0, which normalized by D10 after expansion. Patient-derived CD123 CAR-T cells efficiently eliminated pDCs in vitro and in vivo and migrated to inflamed skin. In mice, CAR-T cell treatment reduced pDC skin infiltration, restored epidermal architecture, and decreased psoriasiform inflammation. CONCLUSION: Autologous T cells from IMID patients can generate functional CD123 CAR-T cells comparable to healthy donors. These cells effectively deplete pDCs and improve psoriasis-like skin pathology, supporting their potential as a novel cell-based therapy in pDC-driven IMIDs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Univeristé Marie et Louis Pasteur, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France; Autoimmunity and Allergology Laboratory, CHU Besançon, Besançon, Fr…
- Franche-Comte Innov à Besançon, Bionoveo, Besançon, France.
- EFS Bourgogne/Franche-Comté, Laboratoire de Contrôle Qualité des MTI, Besançon, France.
- Univeristé Marie et Louis Pasteur, INSERM, EFS BFC, UMR1098, RIGHT Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.
- Service Anatomo-pathologie CH Trévenans, Trévenans, France.
- Service de Médecine Interne, CH Louis Pasteur, Dole, France.
Zitieren
APA
Caël, B., Bôle-Richard, E., Belakri, I., Zuffo, L. D., Mazars, J., Humbert, S., Sônego, F., Creusat, F., Thiam, K., Galaine, J., Aubin, F., & Garnache-Ottou, F. (2026). Functional evaluation of chimeric antigen receptor T-cell anti-CD123 from immune-mediated inflammatory disease patients for novel plasmacytoid dendritic cell–targeted immunotherapy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.08.031
Vancouver
Caël B, Bôle-Richard E, Belakri I, Zuffo LD, Mazars J, Humbert S, et al. Functional evaluation of chimeric antigen receptor T-cell anti-CD123 from immune-mediated inflammatory disease patients for novel plasmacytoid dendritic cell–targeted immunotherapy. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.08.031
BibTeX
@article{Cal2026,
author = {Caël, Blandine and Bôle-Richard, Elodie and Belakri, Imane and Zuffo, Ludivine Dal and Mazars, Jérémy and Humbert, Sebastien and Sônego, Fabiane and Creusat, Florent and Thiam, Kader and Galaine, Jeanne and Aubin, François and Garnache-Ottou, Francine},
title = {Functional evaluation of chimeric antigen receptor T-cell anti-CD123 from immune-mediated inflammatory disease patients for novel plasmacytoid dendritic cell–targeted immunotherapy},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
doi = {10.1016/j.jaci.2026.08.031}
}
EUVIMED